The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.

@article{Ross2009TheUO,
  title={The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.},
  author={Adam H Ross and Philip David Jaycock and S. D. Noam Cook and Andrew D Dick and Derek M Tole},
  journal={The British journal of ophthalmology},
  year={2009},
  volume={93 4},
  pages={421-2, 548}
}
al. Systemic bevacizumab for retinal angiomatous proliferation associated with retinal pigment epithelial detachment. Eur J Ophthalmol 2007;17:987–91. 15. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma [correction appears in N Engl J Med 2007;357:203]. N Engl J Med 2007;356:125–34. 16. Strumberg D, Richly H, Hilger RA, et al. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Sorafenib in advanced clearcell renalcell carcinoma [ correction appears in

  • B Escudier, T Eisen, WM Stadler
  • N Engl J Med
  • 2007

Similar Papers

Loading similar papers…